Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8830144 | Urology Practice | 2018 | 22 Pages |
Abstract
Mitomycin C remains underused, although its use has increased. Patients with increased comorbidities are less likely to receive mitomycin C while high volume surgeons are more likely to administer mitomycin C. Understanding patterns of care in mitomycin C use may inform quality improvement initiatives and guide future efforts to promote appropriate use.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Urology
Authors
Matthew Mossanen, Matthew D. Ingham, Jeffrey J. Leow, Ilker Tinay, Ye Wang, Ross E. Krasnow, Mark A. Preston, Joaquim Bellmunt, Benjamin I. Chung, Jonathan E. Rosenberg, Steven L. Chang,